Keep prostate healthy with statins?

clock •

Trials show cancer rates lower in those taking cholesterol lowering drugs

Taking cholesterol-lowering statins may be an effective way to keep the prostate healthy, the American Urological Association has been told. A study found statins, currently used to lower cholesterol and help prevent heart attacks and strokes, were linked to reduced risk of prostate cancer, and enlargement of the organ, which can cause urinary problems. A second study found statins may hinder prostate cancer growth by reducing inflammation. The US Mayo Clinic followed 2,447 men aged 40 to 79 for 20 years. Men on statins were three times less likely to develop prostate cancer than those ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on uncategorised

Professional Adviser named Retail & Wholesale Publication of the Year

Professional Adviser named Retail & Wholesale Publication of the Year

Aviva Investors Sustainability Media Awards

Professional Adviser
clock 09 November 2026 • 1 min read
PA Awards 2027: Last chance - entries close at midnight tonight

PA Awards 2027: Last chance - entries close at midnight tonight

The 22nd Professional Adviser Awards will take place in London next March

Professional Adviser
clock 18 September 2026 • 1 min read
Multi-Asset and MPS Roadshow: Last chance to join PA in Harrogate or Warrington

Multi-Asset and MPS Roadshow: Last chance to join PA in Harrogate or Warrington

Hear from Aberdeen, Aviva Investors, Clever, Downing, Fidelity, Quilter Cheviot, Rathbones

Professional Adviser
clock 08 September 2026 • 1 min read